This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignee: Inxmed (Nanjing) Co., Ltd.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Baoyuan Zhang: Innovator in Cancer Treatment
Introduction
Baoyuan Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment, particularly in developing methods for targeting tumors with specific genetic mutations. With a total of 3 patents to his name, Zhang is recognized for his innovative approaches in medical science.
Latest Patents
One of Zhang's latest patents focuses on the use of BI853520 in cancer treatment. This invention relates to a method for treating tumors with a KRAS mutation. The method involves administering a compound known as 2-fluoro-5-methoxy-4-[(4-(2-methyl-3-oxo-2,3-dihydro-1H-isoindole-4-oxy)-5-trifluoromethyl-pyrimidine-2-yl)amino]-N-(1-methyl-piperidine-4-yl)benzamide or a pharmaceutically acceptable salt thereof. This compound can be administered alone or in combination with a KRAS inhibitor and/or an MEK inhibitor.
Career Highlights
Baoyuan Zhang is currently associated with Inxmed (Nanjing) Co., Ltd., where he continues to work on groundbreaking research in oncology. His expertise in the field has positioned him as a key player in the development of novel cancer therapies.
Collaborations
Zhang collaborates with notable colleagues, including Zaiqi Wang and Jiangwei Zhang. Their combined efforts contribute to advancing research and innovation in cancer treatment.
Conclusion
Baoyuan Zhang's work exemplifies the impact of innovative thinking in the medical field. His patents and ongoing research are paving the way for new treatment options for cancer patients.